Learning objectives for the webinar are as follows:
1. Provide an evidence-based genetic testing and counseling to persons with ALS
2. Select appropriate testing laboratory and methodology for C9orf72 and other genes
3. Discuss evidence-based, consensus process for guideline development which may be applied to other neurogenetic evaluations
THe description is:
The practice of genetic testing in ALS has been impacted by high patient demand for testing, sponsored testing programs, and a new drug application to the FDA for the first gene-targeted therapy in ALS. However, many challenges exist, including few genetic counselors in ALS clinics, and issues with laboratory methods and reporting. Jennifer Roggenbuck, MS, CGC will present new evidence-based, consensus guidelines for genetic counseling and testing in ALS, a project sponsored by the ALS Association.
Speaker: Jennifer Roggenbuck, Jennifer.Roggenbuck@osumc.edu; Ohio State University
Jennifer Roggenbuck is a genetic counselor and Associate Professor at the Ohio State University, where she studies testing and counseling outcomes and best practices in ALS clinical genetics.